Allogeneic Transplantation for Adult Acute Leukemia in First and Second Remission with a Novel Regimen Incorporating Daily Intravenous Busulfan, Fludarabine, 400 CGY Total-Body Irradiation, and Thymoglobulin-Reference-Cited by-同舟云学术

Allogeneic Transplantation for Adult Acute Leukemia in First and Second Remission with a Novel Regimen Incorporating Daily Intravenous Busulfan, Fludarabine, 400 CGY Total-Body Irradiation, and Thymoglobulin

Published:2007-07 Issue:7 Volume:13 Page:814-821
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Russell James A.,Savoie Mary Lynn,Balogh Alexander,Turner A. Robert,Larratt Loree,Chaudhry M. Ahsan,Storek Jan,Bahlis Nizar J.,Brown Christopher B.,Quinlan Diana,Geddes Michelle,Stewart Douglas A.

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference49 articles.

1. The value of allogeneic bone marrow transplant in patients with acute myeloid leukaemia at differing risk of relapse: results of the UK MRC AML 10 trial;Burnett;Br J Haematol,2002

2. Current controversies: which patients with acute myeloid leukaemia should receive a bone marrow transplantation?—An adult treater’s view [annotation];Burnett;Br J Haematol,2002

3. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute lymphoblastic leukemia in adults: an evidence-based review;Hahn;Biol Blood Marrow Transplant,2006

4. Adverse impact of bone marrow transplantation on quality of life in acute myeloid leukaemia patients; analysis of the UK Medical Research Council AML 10 Trial;Watson;Eur J Cancer,2004

5. Growth and development following marrow transplantation for leukemia;Sanders;Blood,1986

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Busulfan with 400 centigray of total body irradiation and higher dose fludarabine: An alternative regimen for hematopoietic stem cell transplantation in pediatric acute lymphoblastic leukemia;Pediatric Blood & Cancer;2024-01-12

2. Stem Cell Transplant for Acute Lymphoblastic Leukemia;Basics of Hematopoietic Stem Cell Transplant;2023

3. Individualized busulfan dosing improves outcomes compared to fixed‐dose administration in pre‐transplant minimal residual disease‐positive acute myeloid leukemia patients with intermediate‐risk undergoing allogeneic stem cell transplantation in CR;European Journal of Haematology;2022-12

4. Vorinostat Combined with Busulfan, Fludarabine, and Clofarabine Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Leukemia: Long-Term Study Outcomes;Transplantation and Cellular Therapy;2022-08

5. Reduced‐toxicity conditioning regimen with busulfan, fludarabine, rATG, and 400 cGy TBI in pediatric patients undergoing hematopoietic stem cell transplant for high‐risk hematologic malignancies;Pediatric Blood & Cancer;2021-05-22